ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,272.46
0.00%
Dow Jones
39,134.76
0.77%
Gold vs US Dollar
2,364.105
0.13%
Brent Oil
84.975
-0.04%
Bitcoin
64,586.31
-0.36%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. I MAB (IMAB)

  7. I MAB (IMAB) News

I MAB (IMAB)

I MAB
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:IMAB
DateTimeSourceHeadlineSymbolCompany
06/06/202412:14Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMABI MAB
06/06/202412:00PR Newswire (US)I-Mab Appoints Phillip Dennis, MD, PhD, as Chief Medical OfficerNASDAQ:IMABI MAB
05/06/202412:11Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMABI MAB
05/06/202412:00PR Newswire (US)I-Mab Announces Collaboration with Bristol Myers Squibb to Evaluate Givastomig in a Combination Study for Newly Diagnosed Gastric and Esophageal CancersNASDAQ:IMABI MAB
30/05/202422:33Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:IMABI MAB
23/05/202422:11Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMABI MAB
23/05/202422:05GlobeNewswire Inc.I-Mab Announces Encouraging Phase 1 Clinical Data of PD-L1x4-1BB Bispecific Antibody Ragistomig at ASCO 2024NASDAQ:IMABI MAB
22/05/202412:00PR Newswire (US)I-Mab to Participate at the Jefferies Global Healthcare ConferenceNASDAQ:IMABI MAB
30/04/202412:00PR Newswire (US)I-MAB Filed 2023 Annual Report on Form 20-FNASDAQ:IMABI MAB
05/04/202412:00PR Newswire (US)I-Mab to Participate at the 23rd Annual Needham Virtual Healthcare ConferenceNASDAQ:IMABI MAB
02/04/202421:01PR Newswire (US)I-Mab Announces Closing of the Divestiture of Business Operations in ChinaNASDAQ:IMABI MAB
14/03/202421:00PR Newswire (US)I-Mab Reports Full Year 2023 Financial Results and Business UpdateNASDAQ:IMABI MAB
09/02/202421:01Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:IMABI MAB
08/02/202411:07Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IMABI MAB
07/02/202411:52Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMABI MAB
07/02/202411:00PR Newswire (US)I-Mab Signs Agreement to Divest its Assets and Business Operations in ChinaNASDAQ:IMABI MAB
07/02/202401:55Edgar (US Regulatory)Form SCHEDULE 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:IMABI MAB
06/02/202411:34Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMABI MAB
05/01/202411:21Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IMABI MAB
02/01/202422:08Dow Jones NewsADRs Slump; FLJ Group Declines 21%NASDAQ:IMABI MAB
29/12/202311:12Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IMABI MAB
26/12/202311:22Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IMABI MAB
01/12/202319:41Edgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipNASDAQ:IMABI MAB
16/11/202311:43Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IMABI MAB
06/11/202313:00PR Newswire (US)I-Mab Announces Participation at Jefferies and Piper Conferences in NovemberNASDAQ:IMABI MAB
02/11/202312:00PR Newswire (US)Felzartamab Granted Breakthrough Therapy Designation by U.S. Food and Drug Administration (FDA) for Primary Membranous Nephropathy (PMN)NASDAQ:IMABI MAB
01/11/202312:00PR Newswire (US)I-Mab Announces Poster Presentations of 4-1BB Bispecific Antibody Portfolio at SITC 2023NASDAQ:IMABI MAB
16/10/202313:00PR Newswire (US)I-Mab Announces Phase 1 Data of Givastomig at ESMO 2023NASDAQ:IMABI MAB
10/10/202316:04Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IMABI MAB
10/10/202313:24Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMABI MAB
 Showing the most relevant articles for your search:NASDAQ:IMAB

Your Recent History

USOTC
DMAN
Demand Brands (PK)
BIT
UB5M1Y
Unicredit Bank
AMEX
ECJ
BIT
DPAY
L&G Digital Payments UCI...
ASX
NTIOA
Neurotech
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved